We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: CP00734
CAS No: 145038-50-2
Synonyms/Alias: Fmoc-Glu(OMe)-OH;145038-50-2;N-alpha-Fmoc-L-glutamicacidalpha-methylester;AmbotzFAA1720;PubChem13156;SCHEMBL12568245;MolPort-008-267-728;Fmoc-L-Glutamicacidgamma-methylester;ZINC2572681;CF-798;FC1251;AKOS015851495;AKOS016002282;AJ-42065;AK-44532;KB-95910;SC-09503;A7894;FT-0655677;ST24047270;J-300100;Q-101688;N-(9H-Fluorene-9-ylmethoxycarbonyl)-L-glutamicacid5-methylester
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C21H21NO6 |
M.W/Mr. | 383.4 |
Abbr | Fmoc-Glu(OMe)-OH |
InChI | 1S/C21H21NO6/c1-27-19(23)11-10-18(20(24)25)22-21(26)28-12-17-15-8-4-2-6-13(15)14-7-3-5-9-16(14)17/h2-9,17-18H,10-12H2,1H3,(H,22,26)(H,24,25)/t18-/m0/s1 |
InChI Key | RULINAWEYRMHHQ-SFHVURJKSA-N |
Canonical SMILES | COC(=O)CCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 |
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com